Search results

ANSTO shared plans for an Innovation Precinct in southern Sydney at a breakfast event.

ANSTO is responsible for the Little Forest Legacy Site (LFLS) located within the ANSTO Buffer Zone boundary. This site, formerly known as the Little Forest Burial Ground (LFBG), was used by the Australian Atomic Energy Commission (AAEC) during the 1960’s to dispose of waste containing low levels of radioactivity and beryllium oxide (non-radioactive) in a series of shallow trenches. There has been regular monitoring of the site since 1966 and the results have been reported in ANSTO’s environmental monitoring reports.

In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth.

Since the discovery of superconducting Caintercalated graphite (CaC6) the intercalation of epitaxial graphene on SiC(0001) with Ca has been studied extensively in order to achieve superconductivity.

Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.

Within the bulk structure of such glasses, boron is known to be a key actor, as it exhibits intriguing and composition-dependent changes in coordination state that often drive properties.

The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.

Applications are now being accepted for the Industry foundations Scholarship.

Project members of Magnetism.

The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.

The physics and chemistry used at ANSTO is built upon, in significant part, by pioneering female scientists who were sidelined, expelled, or simply not credited appropriately for their achievements.

Hear from our most recent addition to the nandin Innovation Centre, Tomonori Hu, Founder and CEO of Miriad.

ANSTO leverages great science to deliver big outcomes. We partner with scientists and engineers and apply new technologies to provide real-world benefits. Our work improves human health, saves lives, builds our industries and protects the environment.

ANSTO’s Centre for Accelerator Science has been selected as a partner facility in RADNEXT 2030, a major European initiative that provides researchers and industry with access to radiation testing infrastructure for electronics.